US$ 27.03
semaglutide patent expiration us Ozempic, Wegovy and Rybelsus: The patents behind Novo Nordisk's weight-loss drugs What is the patent landscape
Description
2020;371:m4147

A 2023 study published in the Journal of the American Medical Association (JAMA) found that of 10 GLP-1 medications on patent, drug manufacturers listed 19.5 patents per product

They were excluded if they had a prior diagnosis of type 1 or gestational diabetes or received a drug during the month it was approved by the FDA or prior month
Dose changes are best based on a full picture, including appetite, side effects, routine, and weight trend

Medically reviewed by Patricia Hartke, Pharm.D., BCPS Last update: April 22, 2026 Est
"GLP-1s can bolster motivation and self-efficacy, making habits easier to adopt, especially in connection with a digital behavior program built specifically for the GLP-1." "We originally built the GLP-1 Companion to mitigate lean mass lossa common side effect of GLP-1 therapy," continued Cook
